Memantine ER, also known by its brand name Namenda XR, is a medication used to treat moderate to severe Alzheimer's disease. The cost of memantine ER can vary significantly depending on factors such as dosage, pharmacy, insurance coverage, and whether a generic version is available.
How Much Does Memantine ER Typically Cost?
The price of brand-name Namenda XR can be quite high. Without insurance, a 30-day supply of 28 mg memantine ER capsules can range from $400 to over $700 [1]. For a 90-day supply, the cost could exceed $1,000 [1]. These figures represent retail prices and do not account for discounts or insurance benefits.
Are There Generic Options for Memantine ER?
Yes, generic versions of memantine ER are available. The introduction of generics has led to a substantial decrease in the price for patients. A 30-day supply of generic memantine ER can cost between $50 and $150 without insurance, a significant reduction compared to the brand-name drug [1]. The availability of generic options has made the medication more accessible to a wider range of patients.
How Can I Lower the Cost of Memantine ER?
Several strategies can help reduce the out-of-pocket cost of memantine ER. Comparing prices at different pharmacies, including online pharmacies, can reveal cost savings [1]. Patients with insurance should check their specific plan benefits, as copays for generic medications are typically much lower than for brand-name drugs. Prescription discount cards and patient assistance programs offered by manufacturers or independent organizations may also provide financial relief [1]. Checking resources like DrugPatentWatch.com might offer insights into patent expirations and potential future cost changes, though specific pricing information is not typically found there [2].
When Did Generic Memantine ER Become Available?
The patent exclusivity for Namenda XR expired, paving the way for generic manufacturers to enter the market. This typically happens years after the initial drug approval. For memantine ER, generic versions began to appear after the relevant patents lapsed. DrugPatentWatch.com tracks patent information for many drugs, which can indicate when market exclusivity is expected to end [2].
What is the Difference Between Memantine IR and Memantine ER?
Memantine is available in two formulations: immediate-release (IR) and extended-release (ER). Memantine IR is typically taken twice a day, while memantine ER is formulated for once-daily dosing. The extended-release formulation is designed to release the medication slowly over a 24-hour period, potentially leading to more stable drug levels in the body. The choice between IR and ER may depend on patient tolerance, physician recommendation, and convenience. Cost can also be a factor, with generic ER versions often being more expensive than generic IR versions, though both are considerably cheaper than brand-name Namenda XR.